Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Net Cash Flow (2023 - 2025)

Historic Net Cash Flow for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $26.7 million.

  • Upstream Bio's Net Cash Flow rose 28814.99% to $26.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.2 million, marking a year-over-year increase of 37663.66%. This contributed to the annual value of $300.3 million for FY2024, which is 331895.92% up from last year.
  • As of Q3 2025, Upstream Bio's Net Cash Flow stood at $26.7 million, which was up 28814.99% from -$25.9 million recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Net Cash Flow registered a high of $292.9 million during Q4 2024, and its lowest value of -$254.6 million during Q1 2025.
  • Over the past 3 years, Upstream Bio's median Net Cash Flow value was -$4.3 million (recorded in 2024), while the average stood at $3.1 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first soared by 146348.15% in 2024, then crashed by 458441.08% in 2025.
  • Quarter analysis of 3 years shows Upstream Bio's Net Cash Flow stood at -$21.5 million in 2023, then skyrocketed by 1463.48% to $292.9 million in 2024, then crashed by 90.88% to $26.7 million in 2025.
  • Its Net Cash Flow was $26.7 million in Q3 2025, compared to -$25.9 million in Q2 2025 and -$254.6 million in Q1 2025.